A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia

Diabetes Research and Clinical Practice

Volumn 69, Issue 1, 2005, Pages 44-51

  Al Bahrani, Ali I ^a   Bakhiet, Charles S ^a   Bayoumi, Riad A ^a   Al Yahyaee, Said A ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

Apolipoprotein B; Dyslipidaemia; Ischaemic heart disease; Oman; Type 2 diabetes mellitus

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OMAN; RISK ASSESSMENT; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; RISK ASSESSMENT;

EID: 20444471479     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2004.09.011     Document Type: Article

References (21)

1. M. Asfour, A. Lambourne, and A. Soliman High prevalence of diabetes mellitus and impaired glucose tolerance in the Sultanate of Oman: results of the 1991 national survey Diab. Med. 12 1995 1122 1125
2. A. Al-Lawati, A. Riyami, A. Mohammed, and P. Jousihati Increasing prevalence of diabetes mellitus in Oman Diabet. Med. 19 2002 954 957
3. J.A. Al-Lawati, A.J. Mohammed, H.Q. Al-Hinai, and P. Jousilahti Prevalence of the metabolic syndrome among Omani adults Diabetes Care 26 2003 1781 1785
4. S.M. Haffner Management of dyslipidemia in adults with diabetes Diabetes Care 21 1998 160 178
5. American Diabetic Association Standards of medical care for patients with diabetes mellitus Diabetes Care 26 2003 S33 50
6. A.M. Wagner, A. Perez, P. Calvo, R. Bonet, A. Castellvi, and J. Ordonez Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients Diabetes Care 22 1999 812 817
7. A.D. Sniderman, T. Scantlebury, and K. Cianflone Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus Ann. Intern. Med. 18 2001 447 459
8. S.M. Marcovina, J.J. Albers, and F. Dati International Federation of Clinical Chemistry standardization project for measurement of apolipoproteins A-1 and B Clin. Chem. 42 1996 1676 1682
9. V. Valles, A. Carlos, A. Salinas, and A. Francisco Apolipoprotein B and A1 distribution in Mexican urban adults: results of national survey Metabolism 51 2002 508 568
10. A.M. Wagner, O. Jorba, M. Rigla, E. Alonso, J. Ordonez-Lianos, and A. Perez LDL cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetic subjects Acta Diabetol. 39 2002 215 220
11. A.D. Sniderman, B. Lamarche, J. Tilley, D. Seccombe, and J. Frohlich Hypertriglyceridemic hyperapoB in type 2 diabetes Diabetes Care 25 2002 79 82
12. I. Jungner, S. Marcovina, and G. Walldius Apolipoprotein B and A-1 values in 127 576 Swedish males and female, standardized according to the World Organization -International Federation of Clinical Chemistry first international reference materials Clin. Chem. 44 1998 641 649
13. R. Jones, and B. Payne Clinical investigation and statistics in laboratory medicine Assoc. Clin. Biochemists 1997
14. J. Armitage, and R. Collins MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial Lancet 6 2002 7 22
15. S.M. Haffner Management of dyslipidemia in adults with diabetes Diabetes Care 21 1998 160 178
16. J. Goldberg Diabetic dyslipidemia: causes and consequences Clin. Endocrinol. Metab. 86 2001 965 971
17. C. Snehalatha, A. Ramachandran, and S. Sivasankari Is increased apolipoprotein B-A major factor enhancing the risk of coronary artery disease in type 2 diabetes Assoc. Physicians India 50 2002 1036 1038
18. A.M. Wagner, D. Jorba, M. Rigla, E. Alonso, J. Ordonez-Lianos, and A. Perez LDL cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetic subjects Acta Diabetol. 39 2002 215 220
19. P. Bachorik, K. Lovejoy, and M. Carroll Apolipoprotien B and A-1 distributions in the United States, 1988-1991: results of the national health and nutrition examination survey II (NHANES III) Clin. Chem. 41 1995 1633 1636
20. W. Lu, H. Resnick, and K. Jablonski Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes Diabetes Care 26 2003 16 23
21. S. Koba, T. Hirano, and T. Kondo Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease Am. Heart. J. 144 2002 1026 1035